187 related articles for article (PubMed ID: 25302696)
1. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
[TBL] [Abstract][Full Text] [Related]
2. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
[TBL] [Abstract][Full Text] [Related]
3. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
Barnard JG; Singh S; Randolph TW; Carpenter JF
J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
[TBL] [Abstract][Full Text] [Related]
4. Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.
Kalonia C; Kumru OS; Kim JH; Middaugh CR; Volkin DB
J Pharm Sci; 2013 Dec; 102(12):4256-67. PubMed ID: 24122556
[TBL] [Abstract][Full Text] [Related]
5. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
Nishi H; Mathäs R; Fürst R; Winter G
J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
[TBL] [Abstract][Full Text] [Related]
6. Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation.
Davis JM; Zhang N; Payne RW; Murphy BM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
Pharm Dev Technol; 2013; 18(4):883-96. PubMed ID: 22813478
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.
Telikepalli S; Kumru OS; Kim JH; Joshi SB; O'Berry KB; Blake-Haskins AW; Perkins MD; Middaugh CR; Volkin DB
J Pharm Sci; 2015 Feb; 104(2):495-507. PubMed ID: 25522000
[TBL] [Abstract][Full Text] [Related]
8. Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.
Telikepalli S; Shinogle HE; Thapa PS; Kim JH; Deshpande M; Jawa V; Middaugh CR; Narhi LO; Joubert MK; Volkin DB
J Pharm Sci; 2015 May; 104(5):1575-91. PubMed ID: 25753756
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
[TBL] [Abstract][Full Text] [Related]
10. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
Werk T; Volkin DB; Mahler HC
Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
[TBL] [Abstract][Full Text] [Related]
11. Shape Characterization of Subvisible Particles Using Dynamic Imaging Analysis.
Mathaes R; Manning MC; Winter G; Engert J; Wilson GA
J Pharm Sci; 2020 Jan; 109(1):375-379. PubMed ID: 31476311
[TBL] [Abstract][Full Text] [Related]
12. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
[TBL] [Abstract][Full Text] [Related]
13. Variable Threshold Method for Determining the Boundaries of Imaged Subvisible Particles.
Cavicchi RE; Collett C; Telikepalli S; Hu Z; Carrier M; Ripple DC
J Pharm Sci; 2017 Jun; 106(6):1499-1507. PubMed ID: 28209364
[TBL] [Abstract][Full Text] [Related]
14. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
Nayak A; Colandene J; Bradford V; Perkins M
J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
[TBL] [Abstract][Full Text] [Related]
15. Factors Governing the Accuracy of Subvisible Particle Counting Methods.
Ríos Quiroz A; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
J Pharm Sci; 2016 Jul; 105(7):2042-52. PubMed ID: 27287519
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
Gikanga B; Hui A; Maa YF
PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
[TBL] [Abstract][Full Text] [Related]
17. Microflow Imaging Analyses Reflect Mechanisms of Aggregate Formation: Comparing Protein Particle Data Sets Using the Kullback-Leibler Divergence.
Maddux NR; Daniels AL; Randolph TW
J Pharm Sci; 2017 May; 106(5):1239-1248. PubMed ID: 28159641
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
[TBL] [Abstract][Full Text] [Related]
19. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
[TBL] [Abstract][Full Text] [Related]
20. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
Patel AR; Lau D; Liu J
Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
